Stand out for this role — generate a tailored resume and cover letter in about a minute.
Pan American Health Organization (PAHO) in the Region of the Americas is seeking an International Consultancy Regional Consultant on Quality Control Laboratories. The remote, 12-month assignment focuses on strengthening national and regional QCLs for medicines and vaccines under the WHO GBT LT function, with travel within the region as needed.
The role requires senior regulatory laboratory experience, strong writing skills, and bilingual proficiency in Spanish and English.
This is a requisition for employment at the Pan American Health Organization (PAHO)/Regional Office of the World Health Organization (WHO).
Contractual Agreement: Non-Staff - International PAHO Consultant
Job Posting: September 10, 2026
Closing Date: September 20, 2026, 11:59 PM Eastern Time
Primary Location: Off Site
Organization: IMT Innovation, Access to Medicines and Health Technologies
Schedule: Part time
Provide specialized technical cooperation to strengthen national and regional quality control laboratories (QCLs) for medicines, vaccines, and other health technologies within the framework of the WHO Global Benchmarking Tool (GBT), contributing to improvements in regulatory maturity, the development and implementation of Institutional Development Plans (IDPs), and the articulation of regional initiatives on reliance, capacity-building, and laboratory networks — in alignment with CSP30.R12 and PAHO's BWP Outcome 2.3.
International Consultancy (IPC) Band C Regional Consultant on Quality Control Laboratories and the Laboratory Testing Regulatory Function
Contract period: 1 November 2026-31 October 2027
Work modality: Remote, with occasional travel within the Region of the Americas as required
Duty station: Remote — candidates must be based in the Region of the Americas
Hiring entity: Department of Innovation, Access to Medicines and Health Technologies (IMT), Quality and Regulation Unit (IMT/QR)
The Department of Innovation, Access to Medicines and Health Technologies (IMT) is responsible for promoting, coordinating, and executing PAHO's technical cooperation to improve equitable access to health technologies, including pharmaceutical products, vaccines, medical devices, diagnostics, and other products, working in an interprogrammatic manner and in collaboration with key partners. The Quality and Regulation Unit (IMT/QR) provides technical cooperation to strengthen the regulatory systems capacity for health technologies through the promotion of international standards, support to countries in regulatory capacity assessment processes, institutional development planning, and human resources competency building. The Unit also promotes regulatory harmonization and convergence in the Region through the Secretariat of the Pan American Network for Drug Regulatory Harmonization (PANDRH), leads regional technical networks and working groups, and provides technical support to the PAHO Regional Revolving Funds on quality assurance and risk management. This consultancy is part of PAHO's sustained regional efforts to strengthen national and regional quality control laboratories (QCLs) for medicines, vaccines, and other health technologies. Functional and well-resourced QCLs are a cornerstone of national medicines regulatory systems, generating the analytical evidence needed to support marketing authorization decisions, pharmacovigilance, and post-market surveillance, including verification of product quality across the supply chain. In addition to providing technical and scientific input before and after marketing authorization, national QCL staff may also contribute to clinical trial authorizations, participate in regulatory inspections, support the analysis of vigilance data, and provide technical advice for national lot release. Despite significant progress in the Region, strengthening laboratory regulatory capacity remains one of the most technically complex areas of regulatory systems development, requiring specialized expertise, adequate infrastructure, robust quality management systems, and progressive pathways toward international recognition. As part of its mandate to support the evaluation and strengthening of national regulatory authorities (NRAs) in the Region, PAHO uses the WHO Global Benchmarking Tool (GBT) as the standard methodology for regulatory systems assessment. The Laboratory Testing (LT) function—one of nine regulatory functions assessed by the GBT—covers activities ranging from sample reception and testing methods, through quality management and equipment management, to reporting and decision-making. Supporting NRAs and national quality control laboratories (NQCLs) in progressing along the GBT maturity levels—and, where appropriate, pursuing WHO prequalification or international accreditation—is a priority under PAHO's regional regulatory strengthening mandate. IMT/QR's work in this area is guided by the PAHO Regional Policy for Strengthening National Regulatory Systems (CSP30.R12), which calls on Member States to strengthen the laboratory function as part of integrated regulatory systems, and to engage with international harmonization standards. It also aligns with the mandate to support laboratory networks and collaborative initiatives with strategic partners including UNODC, USP, WCO, WHO, WOAH, Interpol, and academic laboratories. To advance this agenda, IMT/QR requires the services of a professional with specialized expertise in QCL operations, the GBT LT function, and regional capacity-building strategies.
To provide specialized technical cooperation to strengthen national and regional quality control laboratories (QCLs) for medicines, vaccines, and other health technologies within the framework of the WHO Global Benchmarking Tool (GBT), contributing to improvements in regulatory maturity, the development and implementation of Institutional Development Plans (IDPs), and the articulation of regional initiatives on reliance, capacity-building, and laboratory networks — in alignment with CSP30.R12 and PAHO's BWP Outcome 2.3.
All products shall be delivered in PDF format, submitted electronically (via email or other method designated by PAHO), within the timelines agreed with the supervisor. The remuneration corresponds to PAHO Band C consultant rates. The total value of the contract is US$ 84,000 with an estimated dedication time of 80%. Payments will be made in installments upon submission and acceptance of deliverables by the supervisor according to the following schedule:
No. Deliverable / Description / Due date / Payment date / Amount (US$)
1 / Inception report: detailed work plan and activity schedule for the 12-month period; preliminary mapping of prioritized countries and baseline status of the Laboratory Testing function; proposed mandate, structure, and membership of the two technical working groups. / 18-Dec-26 / 21-Dec-26 / $14,000
2 / First progress report: early advances in technical assistance to at least two prioritized countries; kick-off documentation of both working groups (meeting summaries and agreed workplans); initial mapping of regional reliance practices in laboratory testing. / 26-Feb-27 / 28-Feb-27 / $14,000
3 / Second progress report: advances in IDP laboratory components (minimum two countries); Reliance WG — preliminary regional technical guidance on reliance in laboratory testing (for consultation); / 26-Apr-27 / 30-Apr-27 / $14,000
4 / Third progress report: consolidated mid-year review — technical assistance outcomes (minimum three countries), IDP status, and results of technical missions and partner activities; Reliance WG — revised guidance document incorporating consultation feedback. / 26-Jun-27 / 30-Jun-27 / $14,000
5 / Fourth progress report: Training WG — at least two finalized learning resources (courses, modules or technical guides) ready for publication on the PAHO Virtual Campus for Public Health (VCPH); documentation of good practices and lessons learned in laboratory strengthening. / 26-Aug-27 / 31-Aug-27 / $14,000
6 / Final consolidated report: full systematization of 12-month results (country technical assistance, working groups, laboratory networks, partner activities, training resources produced); lessons learned; recommendations for program continuity; proposed work plan for the following period. Includes finalized versions of all outstanding products. / 26-Oct-27 / 31-Oct-27 / $14,000 TOTAL US$ 84,000
Travel, daily subsistence allowances, and related mission costs are governed by applicable PAHO policies and are not included in the consultancy fee.
The consultancy will cover an initial period of twelve (12) months, from 1 November 2026 to 31 October 2027, with the possibility of an extension for up to an additional six (6) months (for a total 18 months), subject to fund availability, operational needs of IMT/QR, and satisfactory performance evaluation.
The work modality is remote. The consultant must be based in the Region of the Americas. Occasional travel to prioritized countries in the Region may be required for technical missions, GBT assessments, workshops, or meetings with strategic partners. Travel and daily subsistence allowances will be governed by applicable PAHO policies and are not included in the consultancy fee.
The consultant will report to the Advisor, Regulatory System Strengthening for Medicines & other Health Technologies, and will work in close coordination with the IMT/QR technical team and, as appropriate, with PAHO country offices. A minimum of monthly check-in meetings will be held to review progress, in addition to operational coordination as needed.
This consultancy contributes directly to PAHO's BWP Outcome 2.3: "Access to health technologies, innovation, and production", through the strengthening of the Laboratory Testing regulatory function, the development of NRA technical capacities, the promotion of reliance in laboratory testing, and the fostering of regulatory harmonization and convergence in the Region of the Americas — in implementation of the mandates of resolution CSP30.R12.
Essential Requirements
Desirable Characteristics
This vacancy notice may be used to identify candidates for other similar consultancies at the same level. Successful candidates will be placed on the roster and subsequently may be selected for consultancy assignments falling in this area of work or for similar requirements/tasks/deliverables. Inclusion in the Roster does not guarantee selection for a consultant contract. There is no commitment on either side. Only candidates under serious consideration will be contacted. For information on PAHO please visit: http://www.paho.org . PAHO/WHO is committed to providing a respectful and supportive workplace for all personnel . PAHO is an ethical organization that maintains high standards of integrity and accountability. People joining PAHO are required to maintain these standards both in their professional work and personal activities. PAHO also promotes a work environment that is free from harassment, sexual harassment, discrimination, and other types of abusive behavior. PAHO conducts background checks and will not hire anyone who has a substantiated history of abusive conduct. PAHO personnel interact frequently with people in the communities we serve. To protect these people, PAHO has zero tolerance for sexual exploitation and abuse. People who commit serious wrongdoings will be terminated and may also face criminal prosecution. PAHO/WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco. Applications from women and from nationals of non and underrepresented Member States are particularly encouraged. Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. The execution of the work under a consultant contract does not create an employer/employee relationship between PAHO and the Consultant. PAHO/WHO shall have no responsibility whatsoever for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by PAHO/WHO.
PAHO is the specialized international health agency for the Americas. It works with countries throughout the region to improve and protect people's health. PAHO wears two institutional hats: it is the specialized health agency of the Inter-American System and also serves as Regional Office for the Americas of the World Health Organization (WHO), the specialized health agency of the United Nations. PAHO engages in technical cooperation with its member countries to fight communicable and noncommunicable diseases and their causes, to strengthen health systems, and to respond to emergencies and disasters. PAHO is committed to ensuring that all people have access to the health care they need, when they need it, with quality and without fear of falling into poverty. Through its work, PAHO promotes and supports the right of everyone to good health. To advance these goals, PAHO promotes technical cooperation between countries and works in partnership with ministries of health and other government agencies, civil society organizations, other international agencies, universities, social security agencies, community groups, and other partners. PAHO promotes the inclusion of health in all public policies and the engagement of all sectors in efforts to ensure that people live longer, healthier lives, with good health as their most valuable resource. Under the leadership of its 51 member countries and territories, PAHO sets regional health priorities and mobilizes action to address health problems that respect no borders and that, in many cases, jeopardize the sustainability of health systems. From its Washington, D.C., headquarters, 27 country offices and three specialized centers in the region, PAHO promotes evidence-based decision‑making to improve and promote health as a driver of sustainable development.